Global Health

Global Health FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Global Health (GLH.AX) as of Sep 27, 2026 is 54.07 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 101.42 % — a change of -46.68% (lower).

FCF Conversion

54.07 %

YoY

-46.68%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Global Health is 2026 54.07 % . FCF Conversion Rate (FCF/EBITDA) of Global Health was 2025 101.42 % . It decreases by -46.68% lower compared to the previous year.

The Global Health FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2016
-1,013.20 AUD
Jan 1, 2017
134.87 AUD
Jan 1, 2018
112.62 AUD
Jan 1, 2019
47.56 AUD
Jan 1, 2020
1,397.50 AUD
Jan 1, 2021
-138.36 AUD
Jan 1, 2022
101.42 AUD
Jan 1, 2023
54.07 AUD
The Global Health FCF Conversion history
YEARFCF ConversionYoY
54.07 %-46.68%
101.42 %-173.30%
-138.36 %-109.90%
1,397.50 %+2,838.68%
47.56 %-57.77%
112.62 %-16.50%
134.87 %-113.31%
-1,013.20 %+1,707.01%
-56.07 %-369.14%
20.83 %—
Access this data via the Eulerpool API

Global Health Stock analysis

What does Global Health do? Global Health Ltd is a British company that has been operating in the healthcare industry since 2004. Its foundation was a response to the increasing demand for better access to healthcare in developing countries. The company has continuously expanded and improved its business model to meet the changing demands of the healthcare industry. An important aspect of Global Health Ltd's business model is its collaboration with governments and non-governmental organizations (NGOs). The company provides comprehensive consultation services to assist governments in planning, developing, and implementing healthcare programs. This includes improving vaccination programs, strengthening healthcare systems, and developing strategies to reduce diseases. Through partnerships with NGOs, Global Health Ltd also enables access to healthcare services in rural and remote areas. The company also provides services in the field of medical research and development, working closely with academic institutions, non-profit organizations, and pharmaceutical companies to promote the development of new drugs and vaccines and support clinical research. Global Health Ltd offers specialized divisions focused on specific areas of the healthcare industry. For example, the company provides medical devices and equipment, including mobile healthcare solutions, to meet the increasing importance of digital technology in healthcare. Additionally, Global Health Ltd is involved in training and education for medical professionals, including training programs for healthcare personnel in developing countries and training for pharmaceutical companies and clinical research institutions. Another important division of the company is its healthcare services, operating healthcare centers in various countries, including clinics that offer specialized services such as ophthalmology, gynecology, and obstetrics. These healthcare centers aim to provide high-quality healthcare at affordable costs and serve as important sources of healthcare and prevention in many regions. Global Health Ltd also offers nutritional supplements specifically tailored to the needs of children and pregnant women. These products are developed and manufactured in collaboration with health authorities and NGOs in developing countries to combat malnutrition and deficiencies. Through its diverse offerings and collaborations with governments, NGOs, and other stakeholders, Global Health Ltd is committed to improving access to healthcare worldwide. The company strives to enable sustainable and affordable healthcare for all, making an important contribution to the global health agenda. Global Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Global Health stock

FCF Conversion Rate (FCF/EBITDA) of Global Health is 54.07 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Global Health changed from 101.42 % to 54.07 %, representing a -46.68% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Global Health since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Global Health with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

Cash Flow — Global Health

All Key Metrics — Global Health